Trials / Sponsors / Bond Avillion 2 Development LP
Bond Avillion 2 Development LP
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Comparison of PT027 vs PT007 Used as Needed in Participants With Asthma Asthma | Phase 3 | 2022-09-02 |
| Completed | To Compare the Pharmacokinetics of Budesonide Delivered by BDA MDI to Budesonide Delivered by Pulmicort Respul Asthma | Phase 1 | 2021-05-06 |
| Completed | A Study to Assess the Efficacy of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) on Exercise-induce Exercise Induced Bronchospasm | Phase 3 | 2020-01-15 |
| Completed | A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered Dose Inhaler (BDA MDI/PT027) Used 4 Asthma | Phase 3 | 2019-03-20 |
| Completed | A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) in Adul Asthma | Phase 3 | 2018-12-13 |
| Completed | A Phase 2b Study of the Efficacy, Safety, and Tolerability of M1095 (Sonelokimab) in Subjects With Moderate to Psoriasis | Phase 2 | 2018-07-31 |